NEW YORK, Feb. 16 Reportlinker.com announces that a new market research report is available in its catalogue:
The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration
Advertisement
http://www.reportlinker.com/p0177850/The-Future-of-Nutrigenomics-New-opportunities-in-personalized-nutrition-and-food-pharma-collaboration.html
Nutrigenomics explores how nutrients or bioactive dietary compounds can influence gene expression and an individuals risk to certain diseases. Nutrigenetics is the study of how variations in an individual's genetic makeup can increase or decrease the need for a specific nutrient or bioactive food component. Nutrigenomics has the potential to impact various parts of the food chain including the genetic modification of crops and animal feeds, the development of nutrigenomic tests to monitor food safety and personalization of diets, as well as the identification of nutritional supplements and nutrigenomic based products which may offer potential health benefits. The consumer environment is driving growth in the Nutrition & Health market. Over the past decade, consumers have become more concerned for their health and are increasingly inclined to invest in DTC nutrigenetic tests to assess their risk of disease and obtain dietary advice. Healthcare providers too, are keen to shift some of the burden of healthcare costs to individuals and recognize that the personalization of nutrition may be beneficial. The Health and nutrition market is currently worth around $485 billion. This report reviews the business strategies of leading companies regarding the adoption of nutrigenomic technologies and establishment of public-private partnerships as well as potential opportunities for biomarker discovery with the pharma and diagnostic industry to personalize nutrition and medicine.
Advertisement
Table of Contents
The Future of Nutrigenomics
Executive summary 10
Defining nutrigenomics 10
Market drivers 11
Collaborative nutrigenomic research & consortia 12
Leading food & drinks companies: nutrigenomic strategies 13
Leading nutrigenomic testing companies 14
Opportunities: convergence of pharma & diagnostics 15
Challenges: regulation, ethical & IP issues 16
Conclusions 17
Chapter 1 Defining nutrigenomics 20
Summary 20
Introduction 21
'Omic technologies 23
Nutrigenomics and the food & drinks industry 26
Nutrigenomics & food products 28
Nutrigenomics & personalized nutrition 28
Report outline 29
Chapter 2 Market drivers 32
Summary 32
Introduction 33
Drivers for personalized nutrition 34
Healthy aging 34
Consumer demographics 36
Chronic non-communicable disease 38
Urbanization and the emerging markets 40
Global health economics 41
Conclusions on drivers for personalized nutrition 42
Chapter 3 Collaborative nutrigenomic research & consortia 46
Summary 46
Introduction 47
Nutrigenomic research consortia 47
Nutrigenomic research in the EU 49
The European Nutrigenomics Organization (NuGO) 49
DiOGenes 51
TI Food and Nutrition 51
Vision EpiFood Project 53
Canada Foundation for Innovation (CFI) 53
Public-private in age-related diseases 53
Nutrigenomic research in the US 55
Public-private partnership: genetically modified crops 57
Nutrigenomic research across the world 58
International Society of Nutrigenetics/Nutrigenomics (ISNN) 58
Conclusions 59
Chapter 4 Leading food & drinks companies: nutrigenomic strategies 62
Summary 62
Introduction 63
Ingredients manufacturers approach to nutrigenomics 64
BASF 64
Chr Hansen 66
DSM 69
Food manufacturers' approach to nutrigenomics 73
Group Danone 73
Nestlé 76
Unilever 78
Pharma industry M&A in consumer nutrition 80
The evolving open network model 82
Co-development opportunities 86
Areas for market growth & time scales 88
Conclusions 90
Chapter 5 Leading nutrigenomic testing companies 94
Summary 94
Introduction 95
Market leaders 95
23andme.com 97
GeneLink 98
Gene Smart 98
Genova Diagnostics 99
Interleukin Genetics Inc 100
WellGen Inc. 102
Conclusions 104
Chapter 6 Opportunities: convergence of pharma & diagnostics 108
Summary 108
Introduction 109
Nutrigenomics vs pharmacogenomics 110
Global health issues treatment vs prevention 115
Convergence of the pharmaceutical & diagnostic market 116
Conclusions 118
Chapter 7 Challenges: regulation, ethical & IP issues 120
Summary 120
Introduction 121
Regulation of nutrigenomic foods 122
Europe 123
Japan 124
Regulation of nutrigenomic tests 125
Ethical issues 127
Public awareness & perceptions 128
Intellectual Property 129
Conclusions 131
Chapter 8 Conclusions 134
Summary 134
The food & drinks market 135
Global genetic testing market 136
Market trends 136
Overall conclusions 137
Appendix 140
Primary research methodology 140
Acknowledgments 141
Glossary 142
Index 145
Bibliography 148
Endnotes 151
List of Figures
Figure 1.1: Nutrigenetics and nutrigenomics 22
Figure 1.2: The 'omics technologies 24
Figure 1.3: The functional genomic tool box 26
Figure 1.4: Applications of nutrigenomics in the food chain 27
Figure 2.5: Drivers for the food & drinks industry 33
Figure 2.6: The ageing population a driver for personalized nutrition 35
Figure 2.7: Personalized nutrition targeting consumer segments 36
Figure 2.8: Population over 60: world and developed regions (1950-2050) 37
Figure 2.9: Nutritional challenges - obesity & metabolic syndrome 38
Figure 2.10: Growth in consumers in developing & emerging countries (2008-2018) 40
Figure 2.11: Healthcare expenditure as a share of GDP (2006) 41
Figure 2.12: Target population of nutrigenomic based products 43
Figure 4.13: BASF approach to gene discovery 65
Figure 4.14: DSMs sales growth targeting four emerging business areas 70
Figure 4.15 DSMs R&D competencies 72
Figure 4.16 An International and interdisciplinary network 75
Figure 4.17 Diversify & de-risk through externalization 84
Figure 4.18 Open network model 85
Figure 4.19: Waves of nutrigenomic development 90
Figure 5.20: WellGen's nutrigenomic based discovery 103
Figure 6.21: Nutrigenomics vs pharmacogenomics 111
Figure 6.22: Relationship of drugs, disease, genes and gene products 113
Figure 8.23: Health and nutrition market segments (2009) 135
Figure 8.24: Nutrigenomic impact on personalized nutrition 139
List of Tables
Table 3.1: European Consortia and Nutrigenomic Research Programs 50
Table 3.2: Nutrigenomics Network Programs 55
Table 4.3: Stakeholders in nutrigenomic research and personalized nutrition 63
Table 4.4: Chr Hansen - strategic alliances & investments 67
Table 4.5: Nestlé nutrigenomic alliances & investments 77
Table 4.6: Divestment of Animal, Consumer & Medical Nutrition Divisions 80
Table 4.7: Consumer Health Divisions of Pharmaceutical Companies 81
Table 4.8: Alliance between Food, Pharma, Biotech and the Diagnostic Industries 82
Table 5.9: Categorization of genetic variations that may be included in nutrigenomic tests 96
Table 5.10: Categorization of genetic variations that may be included in nutrigenomic tests 97
Table 6.11: Known diet- gene interactions 112
Table 6.12: Known gene-nutrient interactions 114
To order this report:
Genomics Industry: The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
